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Summary 
The case of a patient whose imaging tests indicated liver cirrhosis is presented. The detailed 
diagnostic reveals advanced hepatocellular carcinoma (HCC). Alpha-fetoprotein and a blind liver 
biopsy was necessary. The authors conclude that in oncological surveillance of patients with 
cirrhosis, not only ultrasound but also AFP should be included. 
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Case presentation 
The 57-year-old patient had appeared in the hospital emergency department due to the general 
weakness and pain in the right lower part of the chest lasting about 2-3 weeks. He lost weight 
unintentionally - several kilos in a few months (he was unable to specify values and period more 
precisely). In addition to the reported problems, so far he has not had other health disorders. He 
claimed he was not taking any medications. From unhealthy behaviors he confirmed only the 
occasional consumption of alcohol. There were no family burdens. In the physical examination, the 
liver was enlarged by a few centimeters and the palpable soreness of the ribs arches in the right part 
of the chest was confirmed. Chest x-rays showed the fracture of the fourth right rib. Ultrasound 
examination of the abdominal cavity revealed a nodal lesion in the hepatic hilar area in size of the 
36 x 37 x 87 mm. There were no significant abnormalities in blood count. However abnormalities in 
lab liver tests was found: aspartate aminotransferase 82U/l (N<40), alanine aminotransferase 23 
(N<41), gamma glutamyl transpeptidase 555 U/l (N<55), alkaline phosphatase 277 U/l (N<140), 
bilirubin 0,99 mg/dl (N<1,20). Therefore, an abdominal CT was performed stating the liver 
enlarged to 247 mm in the mid-clavicular line with irregular margin and nodular structure, with an 
enlarged caudate lobe - the image suggested liver cirrhosis. Moreover, the lymph node bundle 
between the aorta and the inferior vena cava, spleen enlargement, metastases to the ribs and thoracic 
spine but also portal vein thrombosis, were diagnosed. Symptomatic treatment of reported 
complaints and anticoagulant therapy due to thrombosis had begun. The diagnostic procedures were 
continued. The alpha-fetoprotein test showed a remarkably high value (6701 ng / ml, N <7.0). 
Endoscopic examination of the upper and lower gastrointestinal tract did not reveal the possible site 
of the onset of neoplastic disease. A blind biopsy of the liver from two different sites was performed 
- both of them confirmed the cancer cells. The patient was qualified for further oncological 
treatment. 
 
Disscusion 
Liver cirrhosis is a disease that predisposes to hepatocellular carcinoma (HCC). Thus, the cirrhotic 
patients must be under the surveillance towards the possible occurrence of hepatocellular 
carcinoma. It is realized by performing ultrasound every 6 months [1]. Some studies shows cirrhosis 
diagnosed at the same time as HCC. Many patients did not realized the fact of liver chronic diseases 
until advanced HCC is confirmed [2]. Macroscopically, HCC can be monofocal, multifocal or in the 
form of diffuse infiltrative cancer - extensive, occupying almost the whole organ. Because there is 
no typical tumour, this type macroscopically often resembles cirrhosis [3, 4, 5]. Moreover it is 
important difficulty due to frequency – infiltrative HCC makes up 23% of all hepatocellular 
carcinomas [5]. Nodular lesions in the liver in the presented patient, and especially the enlargement 
of the caudate lobe, contributes to radiological relevant suspicion of liver cirrhosis, without 
explicitly identifying the tumor [6]. AFP was very suggestive and a blind biopsy of the liver 
revealed the diffuse infiltrative form of HCC. 
 
Conclusion 
Although surveillance guidelines for patients with cirrhosis require abdominal ultrasound every six 
months, without alpha-fetoprotein examination, it should be taken into account that the suitability of 
this form of surveillance in case of diffuse infiltrative cancer is very limited. Therefore, the 
presented case justifies reconsidering the inclusion of combined AFP and ultrasound for screening. 
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